Skip to Main Content
Skip Nav Destination

Industry News + Announcements

We thank our industry partners and advertisers for supporting JIPO, and we encourage our readers to explore the latest headlines from these organizations below. 

------------------------------------------------------------------------------------------------------------------------------------

10th International Gastrointestinal Cancer Conference: Dec 2-6, 2020


November 10, 2020 - The 10th International Gastrointestinal Cancers Conference (IGICC) will be held between 2-6 December 2020. This year virtual IGICC conference will include all gastrointestinal, hepatobiliary, pancreatic malignancies as well as NETs, GISTs and gastrointestinal lymphomas and issues related to the care of patients with gastrointestinal cancer. Please visit the conference website for details of the meeting and free registration: http://igicc.org/

Download invitation from Prof Dr. Suayib Yalcin


------------------------------------------------------------------------------------------------------------------------------------

Top 10 Articles Published in JIPO: April-September 2020

October 15, 2020 - In JIPO, the #1 most read and most downloaded article in 2020 is “Extracellular Signal-Regulated Kinase (ERK) Inhibitors in Oncology Clinical Trialsby Haelee M. Chin, David K. Lai, and Gerald S. Falchook. This article has been viewed more than 1000 times and downloaded more than 175 times.

Another popular JIPO article, with more than 700 views and 150 downloads, is “Are cancer patients at higher risk of death with COVID-19” by Jacob J. Adashek, Joud Hajjar, Roy F. Chemaly, and Razelle Kurzrock.

Also, be sure to read classic editorial by Dr. Aung Naing, Editor in Chief of JIPO, entitled “Being realistic and optimistic in curing cancer.” This article has been viewed and downloaded more than 1000 times in 2020 alone.

Download the full top 10 list here

------------------------------------------------------------------------------------------------------------------------------------

Speaker Interview: TIGIT and the New Wave of Immune Checkpoint Inhibitors

October 1, 2020 - Dr. Dhan Chand (Scientific Director Head of Drug Discovery, Agenus Inc.) discusses the challenges and promise in developing the next clinically validated checkpoints. Download here.

------------------------------------------------------------------------------------------------------------------------------------



Interested in advertising? Please visit https://innovativehci.com/advertising.

Close Modal

or Create an Account

Close Modal
Close Modal